24 /100
LOW RISK
Score updated May 30, 2026

SER — Serina Therapeutics, Inc. Dilution Risk Tracker

Track SER dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SER — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
45
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

Watch
Minor dilution signals detected
15%
🔄 Reverse Split 30%
• 50-day avg $1.97 approaching $1 threshold
🔔 Track SER — Get forecast alerts →

💹 Market Data

Market Cap$27.60M
Shares Outstanding15.00M
Float8.42M
Cash$24.53M
Debt$11.15M
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 425.0K shares
#1 Vanguard Group Inc 180.0K shares
#2 Waverly Advisors, LLC 67.5K shares
#3 Broadwood Capital, Inc. 54.5K shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest323.1K
Days to Cover4.1
% of Float3.8%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2025
Form 4 INSIDER TRANSACTION Mar 23, 2026
Form 4 INSIDER TRANSACTION Mar 19, 2026
Form 4 INSIDER TRANSACTION Feb 02, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track SER Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SER — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for SER
📊 SER FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 SER Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.